Trade AbbVie ^ABBV

Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily

Jim Cramer Says "I Like AstraZeneca Very Much"

AbbVie Targets Post Humira Growth With Cell Therapy And RINVOQ Expansion

Pettee Investors Inc. Trims Stake in AbbVie Inc. $ABBV

What Does Wall Street Think About AbbVie Inc. (ABBV)?

AbbVie Inc. $ABBV Shares Sold by Sollinda Capital Management LLC - Stock Observer

AbbVie Inc. $ABBV Shares Purchased by Jones Financial Companies Lllp - Stock Observer

Elm Partners Management LLC Buys 2,609 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Q4 Earnings: What To Expect

AbbVie Inc. (ABBV): A Bull Case Theory

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study

AbbVie (NYSE:ABBV) Trading 1.2% Higher - Time to Buy?

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Guerra Advisors Inc Increases Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by AGF Management Ltd.

United Community Bank Has $2.39 Million Holdings in AbbVie Inc. $ABBV - Markets Daily

United Community Bank Has $2.39 Million Stake in AbbVie Inc. $ABBV - Stock Observer

Medical Stocks To Keep An Eye On - February 1st - Markets Daily

AbbVie's US$100b Drug Pricing Pact Reshapes Growth And Policy Outlook

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Donaldson Capital Management LLC - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Transcend Capital Advisors LLC

AbbVie Inc. $ABBV Shares Purchased by Thrivent Financial for Lutherans - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Atle Fund Management AB

AbbVie Inc. $ABBV is Donaldson Capital Management LLC's 6th Largest Position - Stock Observer

Thrivent Financial for Lutherans Acquires 34,384 Shares of AbbVie Inc. $ABBV - Stock Observer

Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma

AbbVie Inc. $ABBV Stake Decreased by Keybank National Association OH

National Pension Service Raises Stock Position in AbbVie Inc. $ABBV

AbbVie's US$100b Pledge Raises Questions On Value, Margins And Debt

L.M. Kohn & Company Decreases Stock Position in AbbVie Inc. $ABBV - Daily Political

AbbVie Links U.S. Investment Pledge And Pricing Shift To Cancer Pipeline

AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political

Townsquare Capital LLC Sells 7,540 Shares of AbbVie Inc. $ABBV

Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Markets Daily

Alpha Cubed Investments LLC Raises Stock Position in AbbVie Inc. $ABBV

Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Stock Observer

Citigroup Cuts AbbVie (NYSE:ABBV) Price Target to $230.00 - Daily Political

AbbVie's US Pricing Deal Reframes Growth Prospects And R&D Commitments - Simply Wall St News

TD Waterhouse Canada Inc. Has $26.55 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily

Great Lakes Advisors LLC Decreases Stock Holdings in AbbVie Inc. $ABBV

AE Wealth Management LLC Acquires 18,651 Shares of AbbVie Inc. $ABBV

New York State Common Retirement Fund Sells 129,300 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Stock Holdings Lifted by Fidelis Capital Partners LLC - Stock Observer

Novo Nordisk's Massive Advertising Spend on Wegovy and Ozempic Surpasses Eli Lilly's by 2x in 2025, ETPharma

Why AbbVie Stock Trounced the Market in 2025

AbbVie (NYSE:ABBV) Stock Price Down 2.2% on Analyst Downgrade

Is AbbVie (ABBV) Pricing Reflect Its DCF And Price To Sales Signals After Recent Gains

AbbVie's Irish operations in firing line as Trump targets Botox prices

AbbVie Inc. $ABBV Shares Bought by Mirae Asset Global Investments Co. Ltd.

AbbVie (NYSE:ABBV) Shares Down 2.2% on Analyst Downgrade - Daily Political

Skin Boosters Market to Surpass USD 3,263.80 Million by 2032, Shows New Analysis on Injectable Skin Rejuvenation and Anti-Aging Trends: MMR Statistics

AbbVie Inc. $ABBV Shares Bought by Federated Hermes Inc.

AbbVie Inc. $ABBV Shares Sold by Bank of New York Mellon Corp

Truist Financial Corp Acquires 124,756 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (ABBV) to Release Quarterly Earnings on Wednesday

Does AbbVie's Bispecific Trial Win and R&D Pledge Change The Bull Case For AbbVie (ABBV)?

AbbVie (NYSE:ABBV) Shares Up 1.4% - Still a Buy?

AbbVie Pricing Pact And Cancer Trial Data Reframe Long Term Outlook

TGA issues fake Botox warning over 'significant' health risks

Final Trades: AbbVie, SLB, Amphenol and the IYH

AbbVie (NYSE:ABBV) Price Target Cut to $230.00 by Analysts at Citigroup - Stock Observer

Berenberg Grows More Confident in AbbVie (ABBV) on Skyrizi and Rinvoq Momentum

Why Revolution Medicines Stock Plummeted by Almost 17% Today

RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight

How Recent Price Target Rethinks Are Rewriting The Story For AbbVie (ABBV)

AbbVie Inc. $ABBV Shares Sold by Parthenon LLC | MarketBeat

AbbVie Inc. $ABBV Stake Cut by Lbp Am Sa | MarketBeat

AbbVie Inc. $ABBV Position Cut by Mutual of America Capital Management LLC

Lbp Am Sa Sells 49,377 Shares of AbbVie Inc. $ABBV - Stock Observer

Mutual of America Capital Management LLC Has $47.50 Million Stake in AbbVie Inc. $ABBV - Stock Observer

Vanguard Personalized Indexing Management LLC Increases Stock Position in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Sold by Parthenon LLC - Daily Political

Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials

Sagespring Wealth Partners LLC Has $8.81 Million Holdings in AbbVie Inc. $ABBV - Daily Political

WST: 2026 Drug Delivery Focus And New Syringe Platform Will Support Earnings Power

TrueMark Investments LLC Lowers Position in AbbVie Inc. $ABBV

ABBV: Future Returns Will Hinge On Post-Humira Immunology And Deal Optionality

Mitsubishi UFJ Trust & Banking Corp Has $260.35 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

Resona Asset Management Co. Ltd. Lowers Holdings in AbbVie Inc. $ABBV - Stock Observer

West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio

Strs Ohio Increases Stake in AbbVie Inc. $ABBV - Markets Daily

3 Stocks Including Datadog That May Be Priced Below Their Estimated Value

AbbVie Inc. $ABBV Shares Purchased by Strs Ohio - Stock Observer

Assessing AbbVie (ABBV) Valuation After Positive Phase 3 Epcoritamab Lymphoma Results

2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income

AbbVie Inc. $ABBV Shares Sold by Simplicity Wealth LLC

AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Analysts

AbbVie Cancer Updates Highlight Epcoritamab Data And RC148 Deal For Investors

Diagnosis, risk stratification and management of smouldering multiple myeloma

AbbVie is a top dividend stock as drug pipelines drive payout hikes

208,510 Shares in AbbVie Inc. $ABBV Purchased by Rakuten Investment Management Inc.

Vest Financial LLC Has $72.41 Million Position in AbbVie Inc. $ABBV

Warren Buffett's ETF Pick: Why the Vanguard S&P 500 ETF Remains a Smart Investment

AbbVie's Future: Growth Outlook and Key Challenges Ahead

AbbVie: A Reliable Dividend King for Long-Term Investors

AbbVie: A Dividend King and Pharmaceutical Bargain

Navigating an Overvalued Market: The Vanguard Value ETF as a Defensive Play

AI Podcast: Dollar Weakness and Investment Implications

HSBC: Three 'Painful Trade' Risks Loom if Wall Street Gets It Wrong

Zelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks

Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets

US Government Shutdown: Economic Fallout and Political Impasse

Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty

Global Market Overview: Precious Metals Surge Amidst Economic Uncertainty

Japan LDP-Ishin Policy Talks: Paving the Way for a New Prime Minister?

Israel Prepares to Reopen Rafah Crossing Amid Ceasefire Violation Claims

Fed's Rate Cut Conundrum: An Outlook to 2026